Sotac Pharmaceuticals Limited (NSE:SOTAC)
India flag India · Delayed Price · Currency is INR
128.50
0.00 (0.00%)
At close: Oct 23, 2025

Sotac Pharmaceuticals Company Description

Sotac Pharmaceuticals Limited engages in the production, manufacturing, processing, and sale of various pharmaceutical products in India.

Its therapeutic product portfolio includes anti-diabetic, anti-psychotic, vitamins, minerals, iron supplements, anti-cold, anti-allergic, dermatological solutions, antacid, anti-ulcerants, PPI, anti-emetics, cardiac, anti-hypertensives, analgesic, anti-pyretic, anti-inflammatory, anti-bacterial, anti-viral, general antibiotics, IP-lactams and non-IP-lactams, anti-fungal, and cephalosporin products.

The company also offers non-beta lactam general tablets, beta lactam coated tablets, beta lactam uncoated tablets, non-beta lactam general capsules, beta‐lactam capsules, oral liquid, dry syrup and external preparations such as nasal spray, relief spray and creams.

In addition, it is involved in the research of pharmaceutical molecules used in developing new pharmaceutical formulations; and manufacture of nutraceuticals and food products.

The company also exports its products. Sotac Pharmaceuticals Limited was founded in 2014 and is based in Ahmedabad, India.

Sotac Pharmaceuticals Limited
CountryIndia
Founded2014
IndustryPharmaceutical Preparations
Employees127
CEOSharadkumar Patel

Contact Details

Address:
Plot No. PF-21 & PF-22/A
Ahmedabad, 382110
India
Phone91 99 1356 2852
Websitesotacpharma.com

Stock Details

Ticker SymbolSOTAC
ExchangeNational Stock Exchange of India
Fiscal YearApril - March
Reporting CurrencyINR
SIC Code2834

Key Executives

NamePosition
Sharadkumar PatelChief Executive Officer
Brijeshkumar PatelChief Financial Officer
Pankaj MahabaleshwarkarChief Operating Officer